Loading...
9th Antibody Industrial Symposium 2021 June 22 - 25 2021 | DIGITAL
News Twitter

Previous Edition

AIS2 Congress – The major mAbs & Biotherapy Event in France !

8TH ANTIBODY INDUSTRIAL SYMPOSIUM 2020 – AIS2020
Multispecific Antibodies, Ab-like Molecules & Adoptive Cell Therapy for fighting Diseases




The 8th edition of the Antibody Industrial Symposium AIS2020 was held on November 23rd & 24th 2020 in digital format.
This growing event was this year dedicated to “Multispecific Antibodies, Ab-like Molecules & Adoptive Cell Therapy for fighting Diseases” major theme chosen by the Scientific Advisory Board. The AIS2020 allowed to gather +300 attendees from start-ups, SME, big industrials & academics from +160 different organizations with the will to exchange and make advance the therapeutic antibody field as well as move forward the biotherapy field.

During this 2-days congress, +55 expert speakers shared their experience and expertise throughout 4 Keynote Lectures, 7 plenary tracks, a Pitch Session with 8 new innovative projects, a session dedicated to Intellectual Property and 30 posters on the Poster Virtual Area.
The program included the following sessions:
- Track Multimer Antibody Derivates
- Track Adoptive Cell therapy – CAR-T cells and beyond
- Pitch presentations: New Approaches for Fighting Diseases
- Track Intellectual Property in Immunotherapy: Challenges & Perspectives
- Track Immunocytokines, fusions and beyond
- Track From Preclinical Research to Drug Approval
- Track Complex Biologics, CMC & Developability

More than +300 B2B Virtual meetings took place and exchanges continued after the congress ended, since the platform remained available to all participants for more 6 months, thus promoting interactions and several opportunities to follow up partnerships and business meetings.

7TH ANTIBODY INDUSTRIAL SYMPOSIUM 2019 – AIS2019
HARNESSING THE IMMUNE SYSTEM WITH THERAPEUTIC ANTIBODIES




The 7th edition of the Antibody Industrial Symposium AIS2019 was held on June 24th & 25th 2019 in the Vinci International Convention Centre of Tours.
This growing event was this year dedicated to “Harnessing the Immune System with Therapeutic Antibodies” major theme chosen by the Scientific Advisory Board. The AIS2019 allowed to gather +350 attendees from start-ups, SME, big industrials & academics based in more than 15 different countries with the will to exchange and make advance the therapeutic antibody field.

During this 2-days congress, +30 expert speakers shared their experience and expertise throughout 4 plenary sessions, an Innovation Pitch Session and a session dedicated to Intellectual Property in Immunotherapy. The program included the following sessions:
- Session I – Harnessing the Immune System with Immunomodulatory therapeutic Antibodies
- Session II – Immunomodulation via cell member antigens
- Session III – Pitch presentations: Immunomodulation with therapeutic antibodies new strategies & technologies
- Parallel Session – Intellectual Property in Immunotherapy: Challenges & Perspectives
- Session IV – Immunomodulation via Soluble Antigens
- Session V – Immunomodulation via FC – FcyR interactions

Through this event, 40 Sponsor & Exhibitor companies benefit of the opportunity to showcase their latest innovations, and + 450 B2B meetings took place allowing the attendees to meet new clients and partners.

Sponsors & Exhibitors

PARTNERS

Organization contact
Ana Antunes
17 rue Crépet
69007 Lyon
+33 (0)4 78 02 39 91
ana-sofia.antunes@mabdesign.fr